Lead Programs
Chronic Kidney Disease (CKD)
Cytochroma Inc. is committed to building a product portfolio
of unique Vitamin D therapies that advance the care of patients
with Vitamin D insufficiency and Secondary Hyperparathyroidism
in Chronic Kidney Disease (CKD).
Other Product Candidates
Chronic Kidney
Disease (CKD)
Clinical applications include Vitamin D insufficiency and
Secondary Hyperparathyroidism in Chronic Kidney Disease
(CKD).
- CTAP001 Capsules
Proprietary Vitamin D Product for the treatment of Vitamin
D insufficiency for both the prescription and over-the-counter
markets.
- CTAA101Capsules
and CTAA102 Capsules
CTAA101 Capsules and CTAA102 Capsules for Hyperphosphatemia
in CKD. Novel, orally administered antibody-based
approaches for the treatment of Hyperphosphatemia in patients
with CKD.
Cancer
Clinical applications include prostate cancer.
|